 |
인쇄하기
취소
|
KFDA likely to ban sibutramine-based drugs
Published: 2010-10-12 07:00:00
Updated: 2010-10-12 07:00:00
The Korea Food and Drug Administration (KFDA), which reaffirmed the safety and distribution of sibutramine-based drugs in July, announced its plan on October 9 to review the substance once again after much criticism arose regarding lax monitoring. On October 13, the meeting will decide whether Korea will also shelve the drug.
The U.S. Food and Administration requested the withdrawal of sibu...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.